There are 2 ratings for the drug: SYMMETREL in the Askapatient database.

The average rating for symmetrel is 2.5.
Results are sorted by Date Rating Was Added.    
Please help other patients by adding a rating. [Search by Drug Name] [Research Assistant] [Opinion Polls] [Reports by Treatment Category] [News] [Privacy] [Contact Us] [Home] [FDA Warnings and Alerts for SYMMETREL
]

Key to ratings for symmetrel:
5-Very Satisfied: this medicine cured me or helped me a great deal.
4-Satisfied: this medicine helped.
3-Somewhat Satisfied: this medicine helped somewhat.
2-Not Satisfied: this medicine did not work to my satisfaction.
1-Dissatisfied: I would not recommend taking this medicine.

                    
Page: 1     Results are sorted by Date Rating Was Added.
Rating   Reason Side Effects Comments Sex Age Time Taken Date Added
sort down sort up   F  M  
Change sort order by clicking arrow under column heading.

 1  MS Fatigue Severe depression and suicidal thoughts I took this for one week and after three days I became weepy. It got gradually worse each day until by day 6 I could barely function and on day 7 was considering suicide. This was by far the worst week of my life. The symptoms ceased within 2 days of stopping the meds. F 37 1 weeks 7/24/2008
 4  To relieve MS fatigue Nightmares, throat swelling, trouble sleeping, rash and itching I took this medicine to relieve MS fatigue, and it worked great, but the side effects are not worth the improvement. M 75 1 years 10/2/2007

1  
Average rating for drug: 2.5. This page is printer-friendly; use landscape print with background color turned on.
Key to ratings:
5-Very Satisfied: this medicine cured me or helped me a great deal.
4-Satisfied: this medicine helped.
3-Somewhat Satisfied: this medicine helped somewhat.
2-Not Satisfied: this medicine did not work to my satisfaction.
1-Dissatisfied: I would not recommend taking this medicine.

Askapatient
Drug Database
Enter
Drug Name:

Find Your Medicine Bottle
.

[Rate Your Medicine] [Research Assistant] [Opinion Polls] [Reports] [News] [Home] [Privacy] [Contact Us][Disclaimer]